During and after treatment for acute lymphocytic leukemia (ALL), you will have many tests. These tests check your blood and bone marrow for leukemia cells. They are used to see how well treatment is working. They can also be used to look for signs that the leukemia might have come back.
Terms you may hear
Your ALL might be described with one of these terms:
In remission (or complete remission)
This means:
-
There is no sign of leukemia after treatment.
-
Your blood counts are normal.
-
You have less than 5% immature cells (blasts) in your bone marrow.
Sometimes the term complete molecular remission or complete molecular response is used. This means that leukemia cells cannot be found in the bone marrow even with very sensitive lab tests.
Being in remission doesn’t mean you’re cured. Remission may be permanent, meaning the cancer is cured. But there's no way to know for sure how long a remission may last.
Minimal residual disease
Minimal residual disease (MRD) testing is done routinely as part of ALL treatment. It's often done after induction therapy (the first part of treatment), when it can help predict how well treatment may work.
If you are MRD positive, the ALL appears to be in remission. But very sensitive lab tests are still able to find leukemia cells in your bone marrow. These cells could become active and start to multiply. So the ALL is more likely to come back (relapse). You may benefit from more treatment to try to kill the remaining cells. Or a different treatment may be advised.
MRD negative is a good thing. It means no cancer cells can be found in your bone marrow. People with negative MRD results tend to have longer remissions, which can mean they live longer.
Refractory ALL
The leukemia has not gone away and is not responding to the current treatment. Your healthcare provider will talk with you about other treatment options. These may include more intense doses of chemo or other kinds of chemo.
Relapsed (recurrent) ALL
The leukemia went into remission after the first treatment (induction therapy), but it has come back (relapsed or recurred). Your blood counts may be abnormal again or blasts have reappeared in your bone marrow. Your healthcare provider will discuss treatment options to get your ALL back into remission.
Working with your healthcare provider
Treating cancer is a process. You and your healthcare provider will work together to find the treatments that work best for you.
Featured in
Personalized care starts with the right provider
Search by specialty, location, and more.
FIND A DOCTORRelated Articles
Chronic Myeloid Leukemia (CML): Phases
The phase of CML is one of the most important things to know when deciding how to treat it. The phases note how many immature white blood cells (called blasts) are in the blood or bone marrow. Read on to learn more.
Chronic Lymphocytic Leukemia (CLL): Stem Cell Transplant
Stem cells are immature cells that are the starter cells for all types of body cells. A stem cell transplant uses stem cells to replace bone marrow that contains cancer.
Chronic Myeloid Leukemia (CML): Targeted Therapy
Targeted therapy is often the first treatment used for CML. It is the use of medicines that act on parts of cancer cells that make them different from normal cells. The medicines can damage the cancer cells without affecting most normal, healthy cells. Read on to learn more about this treatment.
Chronic Myeloid Leukemia (CML): Tests After Diagnosis
After a diagnosis of CML, you'll likely need other tests. These tests help your healthcare providers learn more about the cancer and how to treat it.
